Kit formulation of Bevacizumab, an anti-VEGF monoclonal antibody, and consequent labelling with Rhenium-188: initial in vitro and in vivo studies de réir Bouziotis, P, Gourni, E, Xanthopoulos, S, Paravatou, M, Syrigos, K, Loudos, G, Archimandritis, S, Varvarigou, A, Harris, A